Early endothelial alterations in non-insulin-dependent diabetes mellitus

International Journal of Clinical and Laboratory Research

Volumn 28, Issue 2, 1998, Pages 100-103

  Neri, S ^a   Bruno, C M ^a   Leotta, C ^a   D'Amico, R A ^a   Pennisi, G ^a   Ierna, D ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Diabetes; Endothelium; Hemostatic factors; Microalbuminuria; Oxide reductive balance

Indexed keywords

ENDOTHELIN;

ALBUMINURIA; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION; PATHOLOGY; URINE; VASCULAR ENDOTHELIUM;

ALBUMINURIA; DIABETES MELLITUS, TYPE 2; ENDOTHELINS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 0031877833     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050027     Document Type: Article

References (36)

1. Mori TA, Vandongen R, Douglas AJ, McCulloch RK, Burke V. Differential effect of aspirin on platelet aggregation in IDDM. Diabetes 1992; 3:261.
2. Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non insulin-dependent diabetics: a 10 years follow up study of 503 patients. Diabet Med 1988; 5:126.
3. Stiegler H, Standtl E, Shulz K, Roth R, Lehmaker W. Morbidity, mortality and albuminuria in type 2 diabetic patients: a three-year prospective study of a random cohort in general practice. Diabet Med 1992; 9:646.
4. Porta M, La Selva M, Molinatti P, Molinatti GM. Endothelial cell function in diabetic microangiopathy. Diabetologia 1987; 30:601.
5. Osterman H, Van de Loo J. Factors of the hemostatic system in diabetic patients: a survey of controlled studies. Hemostasis 1986; 16:386.
6. Collier A, Wilson R, Bradley H, Thomson JA, Small M. Free radical activity in type 2 diabetes. Diabet Med 1990; 7:27.
7. Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GDO, Small M. Free radical activity and haemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 1992; 41:909.
8. Schimtz A, Ingerslev J. Haemostatic measures in type 2 diabetic patients with microalbuminuria. Diabet Med 1990; 7:521.
9. Collier A, Watson HHK, Patrick AW, Ludlam CA, Clarke BF. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non insulin-dependent) diabetic patients. Diabet Metab 1989; 15:420.
10. Wierusz-Wysocka B, Wysocki H, Byks H, Zozulinska D, Wykretowicz A, Kazmierczak M. Metabolic control quality and free radical activity in diabetic patients. Diabetes Res Clin Pract 1995; 27:193.
11. World Health Organisation Study Group. Diabetes mellitus Technical Report. Series 727. Geneva: WHO: 1985:1-113.
12. Rose GA, Blackburn H. Cardiovascular survey methods. Geneva: World Health Organisation, 1968.
13. Fuller JH, Shipley MJ, Rose G, Jarret RJ, Keen H. Mortality from coronary heart disease risk and stroke in relation to the degree of glycaemia: the Withehall study. B M J 1983; 287:867.
14. Spooner RJ, Weir RJ, Frier BM. Detection of microalbuminuria in diabetic patients using a simple latex agglutination test. Clin Chim Acta 1987; 166:247.
15. Neil A, Hawkins M, Potok M, Throgood M, Cohen D, Mann JA. Prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993; 16:996.
16. Yagi K. Assay for serum lipid peroxide level and its chemical significance. In: Yagi K, ed. Lipid peroxides in biology and medicine. New York: Academic Press; 1982: 223-242.
17. Iversen SA, Cawood P, Dormandy TL. A method for the measurement of a diene-conjugated derivative of linoleic acid, 18:2 (9, 11), in serum phospholipid and possible origins. Ann Clin Biochem 1985; 22:137.
18. Jennings PE, Jones AF, Florkowski CN, Lunec J, Barnett AH. Increased diene-conjugates in diabetic subjects with microangiopathy. Diabet Med 1987; 4:452.
19. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186:407.
20. Paglia DE, Valentine WN. Studies on the quantiative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70:158.
21. Lermon A, Edwards BS, Hallet JW, Henblein DM, Sandberg SM, Burnett SC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl Med 1991; 325:997.
22. Masaki T. Overview: reduced sensitivity of vascular response to endothelin. Circulation 1993; 87:v33.
23. Luscher TF, Oemar BS, Boulanger CM, Hahn AWA. Molecular and cellular biology of endothelin and its receptors. I. J Hypertens 1993; 11:7.
24. Luscher TF, Oeman BS, Boulanger CM, Hahn AWA. Molecular and cellular biology of endothelin and its receptors. II. J Hypertens 1993; 11:121.
25. Ramuzzi G, Benigni A. Endothelins in the control of cardiovascular and renal function. Lancet 1993; 342:589.
26. Kon V, Badr KF. Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 1991; 40:1
27. Iwashima Y, Sato T, Watanabe K, Ooshima E, Hiroishi S, Ishii H. Elevation of plasma thrombomodulin level in diabetic patients with early nephropathy. Diabetes 1990; 39:983.
28. Gruden G, Cavallo-Perin P, Bazzon M, Stella S, Vuolo A, Pagano G. PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994; 43:426.
29. Gutteridge JMC. Free radicals in disease processes: a compilation of causes and consequences. Free Radic Res Commun 1993; 19:141.
30. Shatos MA, Doherty SM, Hoak JC. Alterations in human vascular endothelin cell function by oxygen tree radicals. Arterioscler Thromb 1991; 11-594.
31. Kaji H, Kuraskai M, Ito K, Saito T, Nuoka T, Kojima Y, et al Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non insulin-dependent) diabetic women. Klin Wochenschr 1985; 63:765.
32. O'Brien JR. Shear induced platelet aggregation. Lancet 1990; 335:711.
33. Baynes JW. Role of oxide-reductive stress in the development of complications in diabetes. Diabetes 1991; 40:405
34. Hunt JV, Smith CCT, Wolf SP. Antioxidative glycosylation and possible involvement of peroxides and free radical in LDL modification by glucose Diabetes 1990; 39:1420.
35. HyrataY, Yoshimi I, Takaichi S, Yanagisawa M, Masaki T. Binding and down-regulation of a novel vasoconstrictor endothelin in cultured rat smooth muscle cells. FEBS Lett 239; 13-17, 1988b.
36. Roubert P, Gillard V, Plas P, Guillon JM, Chabrier PE, Braquet P. Angiotensin II and phorbol-esters potently down-regulate endothelin-1 (ET-1) binding sites in vascular smooth muscle cells. Biochem Biophys Res Comm 1989; 164:809